Additional Metadata
Keywords DMARDs (synthetic), methotrexate, rheumatoid arthritis
Persistent URL dx.doi.org/10.1136/annrheumdis-2018-213767, hdl.handle.net/1765/110205
Journal Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases
Citation
Teitsma, X.M. (Xavier M.), Jacobs, J.W.G, de Jong, P.H.P, Hazes, J.M.W, Weel, A.E.A.M, Welsing, P.M.J, … Lafeber, F.P.J.G. (2018). Adding baseline protein biomarkers to clinical predictors does not enhance prediction of treatment response to a methotrexate strategy in early rheumatoid arthritis. Annals of the Rheumatic Diseases: an international peer-reviewed journal for health professionals and researchers in the rheumatic diseases. doi:10.1136/annrheumdis-2018-213767